{"id":"W1983582337","doi":"10.1016/j.pain.2014.03.018","title":"Fasinumab (REGN475), an antibody against nerve growth factor for the treatment of pain: Results from a double-blind, placebo-controlled exploratory study in osteoarthritis of the knee","year":2014,"lang":"en","type":"article","venue":"Pain","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Regeneron Pharmaceuticals","keywords":"Medicine; Tolerability; Placebo; Osteoarthritis; myalgia; Adverse effect; Discontinuation; Knee pain; Anesthesia; Internal medicine","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00276214,0.0003479417,0.000957438,0.0001350102,0.0001244371,0.00002269,0.0002001707,0.0001312656,0.00001456908],"category_scores_gemma":[0.0006944709,0.0001938749,0.0003518446,0.0002217335,0.00009419698,0.0001003136,0.00002957262,0.0001100125,0.000002890932],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001028036,"about_ca_system_score_gemma":0.0001203683,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003012327,"about_ca_topic_score_gemma":0.003517267,"domain_scores_codex":[0.9963182,0.001681657,0.0008039136,0.000457475,0.000390646,0.00034808],"domain_scores_gemma":[0.9956915,0.00279593,0.0003772609,0.0008592445,0.000162136,0.0001139798],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.2600683,0.01097358,0.03308381,0.0001115413,0.0008921629,0.00007385843,0.04481099,0.0000312304,0.03585193,0.0002408657,0.00005964283,0.6138021],"study_design_scores_gemma":[0.8825955,0.05902826,0.005404031,0.0007073674,0.0007561758,0.000002506436,0.01743601,0.00201175,0.0306223,0.0002493027,0.0007329802,0.0004538459],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9887642,0.0008135463,0.0003782757,0.0003321548,0.0002505274,0.008931909,0.0003259116,0.00004016167,0.000163368],"genre_scores_gemma":[0.9978732,0.00006696096,0.0001557587,0.000108641,0.0002004834,0.001201979,0.0001985008,0.00004765972,0.0001467931],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6225272,"threshold_uncertainty_score":0.790599,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03481507113406981,"score_gpt":0.2850686812122734,"score_spread":0.2502536100782036,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}